Day: June 16, 2021

MAYFIELD VILLAGE, OHIO, June 16, 2021 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for May 2021:  May(millions, except per share amounts and ratios; unaudited) 2021   2020   Change         Net premiums written $3,402.4     $3,174.2     7   %Net premiums earned $3,388.8     $2,991.2     13   %Net income $341.1     $366.9     (7 ) %Per share available to common shareholders $0.58     $0.62     (7 ) %Total pretax net realized gains (losses) on securities $146.3     $210.6     (31 ) %Combined ratio 93.1     93.7     (0.6) pts.Average diluted equivalent common shares 586.9     587.2     0   %  May(thousands; unaudited) 2021   2020   ChangePolicies in Force          Personal Lines          Agency – auto 7,986.3   7,336.7   9%Direct –...

Having a security of supply in the power grid of 99,99 percent does not make Halmstads Energi och Miljö AB (HEM) to sit back and relax. Instead, the regional Swedish energy company has declared to make digitalization of the power grid their next step forward. Installing the dInsight Analytics Platform from Dlaboratory Sweden AB (publ) has allowed the company to analyze grid data in-depth and take proactive measures to prevent outages and make grid investments. – The advantage of dLab’s system is that we can find faults in the grid, incidents, and disturbances, before they develop into major outages. This is how we want to work, proactively, before anything has happened, says Jonas Stenberg, electrical engineer at Halmstads Energi och Miljö. The collaboration between HEM and dLab started out as a pilot project in 2018 but by now dLab’s...

The partnership positions both companies to become leaders in the Mexican medical cannabis industry. NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced it has entered into an active pharmaceutical ingredient (“API”) supply agreement with CBD Life Holding SAPI de CV (“CBD Life”), an emerging leader in the Mexican cannabis industry which offers a line of CBD Wellness and consumer products and medical cannabis products which are under development. Under the agreement, Clever Leaves will act as the API supplier for the development and manufacture of CBD Life’s medical cannabis products. Commencing with CBD isolate, Clever Leaves aims to be the ongoing supplier...

Company announcement – No. 39/2021 Zealand Pharma to Present Data on Glucagon Analog, Dasiglucagon, at the 81st Annual American Diabetes Association Scientific SessionsCompany to present six abstracts on ZEGALOGUE®(dasiglucagon) injection, including one oral presentation Data reinforce the Company’s commitment to advancing research and development of new treatment options for people living with diabetes who experience severe hypoglycemiaCopenhagen, DK and Boston, MA, U.S. June 16, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company aspiring to change lives through the development of innovative peptide-based medicines, today announced that it will present five posters, and one oral presentation, at the upcoming 81st Scientific Sessions of the American Diabetes Association (ADA), which is being held virtually...

Xeriant Posts Press Conference and XTI Highlight Videos BOCA RATON, Fla., June 16, 2021 (GLOBE NEWSWIRE) — Xeriant, Inc. (“Xeriant” or the “Company”)(OTC PINK: XERI), a new aerospace technology and advanced materials holding company, announces the Robb Report, “the leading voice in the global luxury market” covered Xeriant’s relationship with XTI Aircraft Company (“XTI”). The Robb Report article stated, “With its two big ducted fans on the wings and a third on the tail, the TriFan 600 looks much different than other VTOLs on the market. Its numbers are impressive: It has a top speed of 345 mph and range of 1,380 miles, with a 29,000-foot cruise altitude.” The entire article is available at the following link: https://robbreport.com/motors/aviation/xtis-trifan-600-1234619199/. Xeriant held a press conference Monday with XTI, at...

BriaCell is expanding its breast cancer platform technology into other cancers including prostate, melanoma, and non-small cell lung cancer. Bria-OTS™, an off-the-shelf personalized immunotherapy for advanced breast cancer, remains on track to enter the clinic in 2021.BERKELEY, Calif. and VANCOUVER, British Columbia, June 16, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces the advancement of its targeted oncology therapeutics into several novel immunotherapy cell lines: Bria-Pros™ for prostate cancer, Bria-Mel™ for melanoma, and Bria-Lung™ for lung cancer. BriaCell’s immunotherapy treatment appeared most effective in breast cancer when the...

• Detroit Diesel will ultimately attribute 100,000 megawatt hours to renewable energy annually through DTE’s MIGreenPower program• Percentage of electricity attributed to renewable energy will increase each year, building up to 100% in 2028• Clean energy commitment supplements Detroit Diesel’s other sustainability initiatives and is the company’s first step to becoming carbon neutral Detroit, June 16, 2021 (GLOBE NEWSWIRE) — Detroit Diesel is the industry leading complete powertrain manufacturer in the North American commercial segment. Today they announced the company’s enrollment in DTE Energy’s MIGreenPower program. MIGreenPower is a voluntary renewable energy program that allows DTE Electric customers to attribute a percentage of their electricity use to DTE’s wind and solar projects. Detroit Diesel has committed to an escalating...

MARIETTA, Ga, June 16, 2021 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that Timothy R. Wright, Chief Executive Officer, Peter M. Carlson, Chief Financial Officer, and Robert B. Stein, M.D., Ph.D., Executive Vice President, Research and Development, will present at the Raymond James 2021 Human Health Innovation Conference on Wednesday, June 23, 2021 at 11:20 AM Eastern Time. Date: Wednesday, June 23, 2021Time: 11:20 AM ETWebcast: https://kvgo.com/rj-health/mimedx-group-inc-june-2021 A live webcast of the presentation will be available on the Events page of the Investors section of the Company’s website at www.mimedx.com or through the conference site by using the link above. A replay will...

SOUTH SAN FRANCISCO, Calif., June 16, 2021 (GLOBE NEWSWIRE) — VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders, today announced the Company will be added to the Russell 2000® Index at the conclusion of the 2021 Russell Indexes annual reconstitution, effective after the U.S. market opens on Monday, June 28, 2021, according to a preliminary list of additions posted on June 4, 2021. “Inclusion in the Russell 2000® Index, which is one of the most cited performance benchmarks for small-cap companies, is another important milestone for VistaGen and an achievement we expect will increase overall awareness...